Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog

F. Ji, F. Huang, A. Juhász, W. Wu, Nicholas Bodor

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Glycopyrrolate is a quaternary anticholinergic drug. Like for other anticholinergics, the usefulness of this agent is limited by its side effects. In this study, based on the structure of glycopyrrolate, we designed a soft drug, methoxycarbonylphenylcyclopentylacetoxy-N,N-dimethyl-3- pyrrolidinium methyl sulfate (SG), and its analog, methoxycarbonylphenylcyclopentylacetoxyethyl-N,N,N-trimethylammonium methyl sulfate (SGA). These soft drugs are expected to be locally active, but systemically inactive in order to increase therapeutic index. SG and SGA were synthesized by (i) carboxylation of methyl phenylcyclopentylacetate, (ii) esterification with N-methyl-3-pyrrolidinol (for SG) or 2-chloro-N,N- dimethylaminoethane (for SGA), and (iii) quarternization with dimethyl sulfate. Receptor binding studies demonstrate that SG has muscarinic subtype selectivity (m3/m2). Guinea pig ileum pA2 assay indicates that activity of SG is moderate, and SG is about ten times more potent than SGA. The in vivo characterization of SG and SGA, both in mydriasis tests and in prevention of carbachol induced bradycardia, supported its soft nature. Applying SG or SGA into rabbit eyes, the dilation of the contralateral (water-treated) pupils was not observed. Glycopyrrolate application, however, caused dilation of the contralateral pupil, indicating a systemic effect of this drug. Cardiac studies were carried out by evaluating the protective effect of soft anticholinergics against carbachol induced bradycardia. The results indicate that SG and SGA were as potent as atropine-MeBr in preventing carbachol induced bradycardia in the rat; however, their durations of action were significantly shorter. In conclusion, the newly synthesized SG and SGA showed soft nature in the body. They are anticholinergics with subtype selectivity and moderate potency, and can be used as topical antiperspirants.

Original languageEnglish
Pages (from-to)187-191
Number of pages5
JournalPharmazie
Volume55
Issue number3
Publication statusPublished - 2000

Fingerprint

Glycopyrrolate
Cholinergic Antagonists
Carbachol
Bradycardia
Pharmacology
Pupil
Pharmaceutical Preparations
Dilatation
Antiperspirants
Carboxylation
Mydriasis
Esterification
Atropine
Ileum
Cholinergic Agents
Rats
Assays
Guinea Pigs
Rabbits
Water

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science

Cite this

Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog. / Ji, F.; Huang, F.; Juhász, A.; Wu, W.; Bodor, Nicholas.

In: Pharmazie, Vol. 55, No. 3, 2000, p. 187-191.

Research output: Contribution to journalArticle

Ji, F, Huang, F, Juhász, A, Wu, W & Bodor, N 2000, 'Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog', Pharmazie, vol. 55, no. 3, pp. 187-191.
Ji, F. ; Huang, F. ; Juhász, A. ; Wu, W. ; Bodor, Nicholas. / Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog. In: Pharmazie. 2000 ; Vol. 55, No. 3. pp. 187-191.
@article{23ab4537a3de4970a6b9fe2b5f06666b,
title = "Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog",
abstract = "Glycopyrrolate is a quaternary anticholinergic drug. Like for other anticholinergics, the usefulness of this agent is limited by its side effects. In this study, based on the structure of glycopyrrolate, we designed a soft drug, methoxycarbonylphenylcyclopentylacetoxy-N,N-dimethyl-3- pyrrolidinium methyl sulfate (SG), and its analog, methoxycarbonylphenylcyclopentylacetoxyethyl-N,N,N-trimethylammonium methyl sulfate (SGA). These soft drugs are expected to be locally active, but systemically inactive in order to increase therapeutic index. SG and SGA were synthesized by (i) carboxylation of methyl phenylcyclopentylacetate, (ii) esterification with N-methyl-3-pyrrolidinol (for SG) or 2-chloro-N,N- dimethylaminoethane (for SGA), and (iii) quarternization with dimethyl sulfate. Receptor binding studies demonstrate that SG has muscarinic subtype selectivity (m3/m2). Guinea pig ileum pA2 assay indicates that activity of SG is moderate, and SG is about ten times more potent than SGA. The in vivo characterization of SG and SGA, both in mydriasis tests and in prevention of carbachol induced bradycardia, supported its soft nature. Applying SG or SGA into rabbit eyes, the dilation of the contralateral (water-treated) pupils was not observed. Glycopyrrolate application, however, caused dilation of the contralateral pupil, indicating a systemic effect of this drug. Cardiac studies were carried out by evaluating the protective effect of soft anticholinergics against carbachol induced bradycardia. The results indicate that SG and SGA were as potent as atropine-MeBr in preventing carbachol induced bradycardia in the rat; however, their durations of action were significantly shorter. In conclusion, the newly synthesized SG and SGA showed soft nature in the body. They are anticholinergics with subtype selectivity and moderate potency, and can be used as topical antiperspirants.",
author = "F. Ji and F. Huang and A. Juh{\'a}sz and W. Wu and Nicholas Bodor",
year = "2000",
language = "English",
volume = "55",
pages = "187--191",
journal = "Die Pharmazie",
issn = "0031-7144",
publisher = "Govi-Verlag Pharmazeutischer Verlag GmbH",
number = "3",

}

TY - JOUR

T1 - Design, synthesis, and pharmacological evaluation of soft glycopyrrolate and its analog

AU - Ji, F.

AU - Huang, F.

AU - Juhász, A.

AU - Wu, W.

AU - Bodor, Nicholas

PY - 2000

Y1 - 2000

N2 - Glycopyrrolate is a quaternary anticholinergic drug. Like for other anticholinergics, the usefulness of this agent is limited by its side effects. In this study, based on the structure of glycopyrrolate, we designed a soft drug, methoxycarbonylphenylcyclopentylacetoxy-N,N-dimethyl-3- pyrrolidinium methyl sulfate (SG), and its analog, methoxycarbonylphenylcyclopentylacetoxyethyl-N,N,N-trimethylammonium methyl sulfate (SGA). These soft drugs are expected to be locally active, but systemically inactive in order to increase therapeutic index. SG and SGA were synthesized by (i) carboxylation of methyl phenylcyclopentylacetate, (ii) esterification with N-methyl-3-pyrrolidinol (for SG) or 2-chloro-N,N- dimethylaminoethane (for SGA), and (iii) quarternization with dimethyl sulfate. Receptor binding studies demonstrate that SG has muscarinic subtype selectivity (m3/m2). Guinea pig ileum pA2 assay indicates that activity of SG is moderate, and SG is about ten times more potent than SGA. The in vivo characterization of SG and SGA, both in mydriasis tests and in prevention of carbachol induced bradycardia, supported its soft nature. Applying SG or SGA into rabbit eyes, the dilation of the contralateral (water-treated) pupils was not observed. Glycopyrrolate application, however, caused dilation of the contralateral pupil, indicating a systemic effect of this drug. Cardiac studies were carried out by evaluating the protective effect of soft anticholinergics against carbachol induced bradycardia. The results indicate that SG and SGA were as potent as atropine-MeBr in preventing carbachol induced bradycardia in the rat; however, their durations of action were significantly shorter. In conclusion, the newly synthesized SG and SGA showed soft nature in the body. They are anticholinergics with subtype selectivity and moderate potency, and can be used as topical antiperspirants.

AB - Glycopyrrolate is a quaternary anticholinergic drug. Like for other anticholinergics, the usefulness of this agent is limited by its side effects. In this study, based on the structure of glycopyrrolate, we designed a soft drug, methoxycarbonylphenylcyclopentylacetoxy-N,N-dimethyl-3- pyrrolidinium methyl sulfate (SG), and its analog, methoxycarbonylphenylcyclopentylacetoxyethyl-N,N,N-trimethylammonium methyl sulfate (SGA). These soft drugs are expected to be locally active, but systemically inactive in order to increase therapeutic index. SG and SGA were synthesized by (i) carboxylation of methyl phenylcyclopentylacetate, (ii) esterification with N-methyl-3-pyrrolidinol (for SG) or 2-chloro-N,N- dimethylaminoethane (for SGA), and (iii) quarternization with dimethyl sulfate. Receptor binding studies demonstrate that SG has muscarinic subtype selectivity (m3/m2). Guinea pig ileum pA2 assay indicates that activity of SG is moderate, and SG is about ten times more potent than SGA. The in vivo characterization of SG and SGA, both in mydriasis tests and in prevention of carbachol induced bradycardia, supported its soft nature. Applying SG or SGA into rabbit eyes, the dilation of the contralateral (water-treated) pupils was not observed. Glycopyrrolate application, however, caused dilation of the contralateral pupil, indicating a systemic effect of this drug. Cardiac studies were carried out by evaluating the protective effect of soft anticholinergics against carbachol induced bradycardia. The results indicate that SG and SGA were as potent as atropine-MeBr in preventing carbachol induced bradycardia in the rat; however, their durations of action were significantly shorter. In conclusion, the newly synthesized SG and SGA showed soft nature in the body. They are anticholinergics with subtype selectivity and moderate potency, and can be used as topical antiperspirants.

UR - http://www.scopus.com/inward/record.url?scp=0034075060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034075060&partnerID=8YFLogxK

M3 - Article

C2 - 10756538

AN - SCOPUS:0034075060

VL - 55

SP - 187

EP - 191

JO - Die Pharmazie

JF - Die Pharmazie

SN - 0031-7144

IS - 3

ER -